Antisecretory factor-inducing therapy improves the clinical outcome in patients with Ménière's disease

Author： Hanner Per   Rask-Andersen Helge   Lange Stefan   Jennische Eva  

Publisher： Informa Healthcare

ISSN： 0001-6489

Source： Acta Oto-Laryngologica, Vol.130, Iss.2, 2010-02, pp. : 223-227

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Antisecretory Factor: A Clinical Innovation in Ménière's Disease?

By Hanner Per   Jennische Eva   Lange Stefan  

Acta Oto-Laryngologica, Vol. 123, Iss. 6, 2003-08 ,pp. : 779-780

Informa Healthcare

Access to resources Recommend Favorite

The relevance of migraine in patients with Ménière's disease

By Cha Y. H.   Brodsky J.   Ishiyama G.   Sabatti C.   Baloh R. W.  

Acta Oto-Laryngologica, Vol. 127, Iss. 12, 2007-01 ,pp. : 1241-1245

Informa Healthcare

Access to resources Recommend Favorite

Intratympanic gentamicin therapy for intractable Ménière's disease

By De Beer Lieke   Stokroos Robert   Kingma Herman  

Acta Oto-Laryngologica, Vol. 127, Iss. 6, 2007-01 ,pp. : 605-612

Informa Healthcare

Access to resources Recommend Favorite

Problems and Solutions for Fitting Amplification to Patients with Ménière's Disease

By Valente Michael   Mispagel Karen   Valente Maureen L.   Hullar Timothy  

Journal of the American Academy of Audiology, Vol. 17, Iss. 1, 2006-01 ,pp. : 6-15

American Academy of Audiology

Access to resources Recommend Favorite

Electrocochleography in the Evaluation of Patients with Ménière's Disease/Endolymphatic Hydrops

By Ferraro John A.   Durrant John D.  

Journal of the American Academy of Audiology, Vol. 17, Iss. 1, 2006-01 ,pp. : 45-68

American Academy of Audiology

Access to resources Recommend Favorite